Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. (March 2017)
- Record Type:
- Journal Article
- Title:
- Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. (March 2017)
- Main Title:
- Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging
- Authors:
- Dziedzic, Dariusz
Piotr, Rudzinski
Langfort, Renata
Orlowski, Tadeusz - Abstract:
- Abstract: Objectives: The paper aimed to compare the efficacy of log odds (LODDS) compared to a classification based on the distribution of involved lymph nodes (pN) and lymph node ratio (LNR). Methods: Material was collected retrospectively from an online survey-based database of the Polish Lung Cancer Group and included a group of 17, 369 patients who received radical surgical treatment (R0) due to lung cancer. Results: In the whole group the median survival for N0, N1 and N2 was 76.1, 41.7 and 24.2 months, respectively. The median survival for individual LODDS categories (−6, -4], (−4, -3], (−3, -2], (−2, -1], (−1, 0], (0, 1] and (1, 2] was 76.5, 76.3, 71.7, 45.4, 25.0, 19.1 and 17.7 months, respectively. The median survival for LNR in individual categories (0), (0, 0.25], (0.25, 05], (0.5075] and (0.75, 1.0] was 75.6, 40.3, 24.1, 18.8 and 16.4 months, respectively. A multi-variant analysis demonstrated that each LODDS category is an independent prognostic factor: (−4, -3] (HR = 0.982; 95% CI 0.867–1.112; P = 0.775), (−3, -2] (HR = 1.114; 95% CI 0.984–1.262; P = 0.089), (−2, -1] (HR = 1.241; 95% CI 1.080–1.425; P = 0.002), (−1, 0] (HR = 1.617; 95% CI 1.385–1.887; P < 0.0001), (0, 1] (HR = 1.918; 95% CI 1.579–2.329; P < 0.0001) and (1, 2] (HR = 2.016; 95% CI 1.579–2.573; P < 0.0001). Conclusions: Based on LODDS it is possible to discriminate patients with regard to lung cancer stage more effectively compared to pN and LNR classification, and it is also a betterAbstract: Objectives: The paper aimed to compare the efficacy of log odds (LODDS) compared to a classification based on the distribution of involved lymph nodes (pN) and lymph node ratio (LNR). Methods: Material was collected retrospectively from an online survey-based database of the Polish Lung Cancer Group and included a group of 17, 369 patients who received radical surgical treatment (R0) due to lung cancer. Results: In the whole group the median survival for N0, N1 and N2 was 76.1, 41.7 and 24.2 months, respectively. The median survival for individual LODDS categories (−6, -4], (−4, -3], (−3, -2], (−2, -1], (−1, 0], (0, 1] and (1, 2] was 76.5, 76.3, 71.7, 45.4, 25.0, 19.1 and 17.7 months, respectively. The median survival for LNR in individual categories (0), (0, 0.25], (0.25, 05], (0.5075] and (0.75, 1.0] was 75.6, 40.3, 24.1, 18.8 and 16.4 months, respectively. A multi-variant analysis demonstrated that each LODDS category is an independent prognostic factor: (−4, -3] (HR = 0.982; 95% CI 0.867–1.112; P = 0.775), (−3, -2] (HR = 1.114; 95% CI 0.984–1.262; P = 0.089), (−2, -1] (HR = 1.241; 95% CI 1.080–1.425; P = 0.002), (−1, 0] (HR = 1.617; 95% CI 1.385–1.887; P < 0.0001), (0, 1] (HR = 1.918; 95% CI 1.579–2.329; P < 0.0001) and (1, 2] (HR = 2.016; 95% CI 1.579–2.573; P < 0.0001). Conclusions: Based on LODDS it is possible to discriminate patients with regard to lung cancer stage more effectively compared to pN and LNR classification, and it is also a better classification system. … (more)
- Is Part Of:
- Surgical oncology. Volume 26:Number 1(2017)
- Journal:
- Surgical oncology
- Issue:
- Volume 26:Number 1(2017)
- Issue Display:
- Volume 26, Issue 1 (2017)
- Year:
- 2017
- Volume:
- 26
- Issue:
- 1
- Issue Sort Value:
- 2017-0026-0001-0000
- Page Start:
- 80
- Page End:
- 85
- Publication Date:
- 2017-03
- Subjects:
- Lung cancer -- Lymph node ratio -- Log odds
Cancer -- Surgery -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Electronic journals
616.994059 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09607404 ↗
http://www.so-online.net/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09607404 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09607404 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.suronc.2017.01.004 ↗
- Languages:
- English
- ISSNs:
- 0960-7404
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8548.242000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2680.xml